O=C(OC1CCOC1=O)c1ccc(N2CCCC2)c([N+](=O)[O-])c1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?